ArticleFolia microbiologica2026
Pomegranate peel extract as a promising tyrosyl-tRNA synthetase inhibitor of Staphylococcus aureus: in vitro and in silico approach.
Article in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Staphylococcus aureus, a common foodborne pathogen, thrives in various environments, including milk, meat, and vegetables. With increasing consumer concerns about the harmful effects of chemical additives, alternative antimicrobial agents are urgently needed. This study evaluates the potential of pomegranate peel extract (PPE) as an inhibitor of the bacterial enzyme tyrosyl-tRNA synthetase (TyrRS). PPE, rich in bioactive compounds such as ellagitannins, ellagic acid, and gallic acid, was extracted using hot water, microwave, and ultrasound methods. The ultrasound assisted extract showed the highest phenol content (178.6 ± 0.6 GAE/g) and antioxidant activity (9.43 ± 1.6 µmole TE/g DW). The MIC value of this extract was found to be 2.0 mg/ml and it inhibited S. aureus growth significantly (20.6 ± 0.31 mm) in agar diffusion tests. To elucidate the molecular mechanism, in silico analyses including molecular docking, molecular dynamics simulations, and MM-PBSA calculations were performed for major PPE-derived phytochemicals, gallic acid, ellagic acid, punicalagin, and punicalin, along with the reference TyrRS inhibitor SB-219,383. Among the tested compounds, punicalagin exhibited the most favorable binding affinity and dynamic stability, with binding free energy comparable to SB-219,383. These findings highlight PPE's potential in combating S. aureus along with utilization of agricultural by-products as source of antimicrobial substance that has the potential of offering a sustainable approach to antimicrobial resistance.
Indexed as
Identifiers
42065831What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.